Global Radiation Therapy Market Report: 2012 Edition

  • ID: 2369745
  • January 2013
  • Region: Global
  • 50 Pages
  • Koncept Analytics
1 of 4


  • Accuray Inc.
  • Elekta
  • Siemens AG
  • MORE

As the technological environment is swiftly undergoing evolution, companies operating in the healthcare/science/pharmaceutical/therapeutic industry are now scaling new heights. Also, the respective sector's growth is boosted by the rising number of health related issues emanating from the changing lifestyle and incessantly evolving surroundings. To address the rising demand for better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved therapies especially in the field of cancer treatment wherein the radiation therapy is gaining quick acceptance.

Radiation therapy (RT) deploys ionized radiation and limits the proliferation of malignant cells by impairing their DNA. Radiation therapy involves the application of various types of radiations including photons, electron beams, proton beams and neutron beams. Also, the treatment regimes are classified as external radiation therapy, internal radiation therapy or brachytherapy and systemic radioisotope therapy.

This report elicits the global radiation therapy market with focus on key regional markets like North America, EMEA, Asia Pacific and READ MORE >

Note: Product cover images may vary from those shown
2 of 4


  • Accuray Inc.
  • Elekta
  • Siemens AG
  • MORE

1. Radiation Therapy (RT)

1.1 Overview

1.2 Types of Radiation Therapy
1.2.1 External-Beam Radiation Therapy
1.2.2 Internal Radiation Therapy
1.2.3 Systemic Radioisotope therapy

1.3 RT Action Mechanism
1.4 RT Effect on Different Cancer Types

2. Radiation Therapy - Market Size

2.1 Global Radiation Therapy Market

Market Value
Growth Rate
Regional Breakdown
Order Growth

2.2 Radiation Therapy Market by Region

2.2.1 North America
2.2.2 EMEA
2.2.3 APAC
2.2.4 Latin America

3. Radiation Therapy - Market Dynamics

3.1 Industry Developments

3.1.1 Development of Proton Therapy
3.1.2 Innovative RapidArc Therapy
3.1.3 Development of Linear Accelerators (LINAC)

3.2 Growth Drivers

3.2.1 Increasing Prevalence of Cancer
3.2.2 Increasing Use of Tobacco and Alcohol
3.2.3 Expanding Obese Population
3.2.4 Rising Demand for Better Healthcare Options
3.2.5 Growing Ageing Population (+60 Years)
3.2.6 Rising Healthcare Expenditure
3.2.7 Increasing Global GNI (Gross National Income)

3.3 Challenges

3.3.1 Patient Safety during the Treatment Process
3.3.2 Highly Fatal Cancers
3.3.3 Rising Costs of Treatment
3.3.4 Stringent Regulatory Measures
3.3.5 Adverse Effects of the Treatment
3.3.6 Escalating Price Pressure

4. Competitive Landscape

4.1 Competitive Scenario by Geographic Region

4.1.1 North America
4.1.2 EMEA
4.1.3 APAC
4.1.4 Japan
4.1.5 China
4.1.6 India

5. Company Profiles

5.1 Varian Medical Systems Inc.

5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
-Focus on Research & Development
-Expanding Product Portfolio

5.2 Elekta

5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
-Partnerships with Research Institutions
-Focus on Product Development

5.3 Accuray Inc.

5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
-Intense Research & Development Activities
-Strategic Collaborations

5.4 Siemens AG

5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
-Accelerating R&D Activities
-Focus on Healthcare Segment

6. Market Outlook

6.1 Market Forecast

6.2 Forecast Methodology

6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Charts

Global Radiation Therapy Market (2001-2011)
Global Radiation Therapy Market by Region (2011)
Radiation Therapy Market CAGR by Region (2001-2011)
Radiotherapy Equipment Order by Region (2009-2013E)
North America's Radiation Therapy Market (2001-2011)
EMEA's Radiation Therapy Market (2001-2011)
APAC's Radiation Therapy Market (2001-2011)
Latin America's Radiation Therapy Market (2001-2011)
Number of Proton Therapy Centers Worldwide (2000-2011)
Number of Cancer Cases Worldwide (2007-2011)
Global Lung Cancer Incidences (2010 & 2030E)
Global Breast Cancer Incidences (2010 & 2030E)
Global Prostate Cancer Incidences (2010 & 2030E)
Growth in Worldwide Obese Population (2004-2012F)
Global Ageing Population (2005-2013F)
Global Healthcare Spending (2005-2015E)
World Gross National Income (2005-2010)
Stages of a Radiotherapy Treatment
Global Radiation Therapy Market Share by Company (2011)
Japan's RT Market Share by Company (FY11/12)
China's RT Market Share by Company (2011)
India's RT Market Share by Company (2011)
Varian Medical Systems' Revenue Share by Business Segments (2011)
Varian Medical Systems' Revenues and Net Earnings (2008-2011)
Elekta's Revenue Share by Business Segments (2011)
Elekta's Revenues and Profit (FY 08/09-FY 11/12)
Accuracy's Revenues and Net Income (2009-2012)
Siemens AG's Revenue Share by Business Segments (2011)
Siemens AG's Revenues and Net Income (2008-2011)
Global Radiation Therapy Market Forecast (2010-2014E)

List of Tables

Estimated Cancer Cases in the US (2012)
Estimated Cancer Deaths in the US (2012)
Patients Worldwide Waiting for Better Treatment Options (2011)
FDA Regulation of Medical Devices
North America's RT Market Share by Company (2011)
EMEA's RT Market Share by Company (2011)
APAC's RT Market Share by Company (2011)
Dependent & Independent Variables (2007–2011)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

Note: Product cover images may vary from those shown
3 of 4

- Accuray Inc.
- Elekta
- Varian Medical Systems Inc.
- Siemens AG

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: A printed copy of the report will be shipped to you.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.


If you have a more general question about our products please try our




Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Inc.
  • Merck & Co., Inc.